Author： Postma Maarten J Welte Robert Morré Servaas A
Publisher： Informa Healthcare
ISSN： 1465-6566
Source： Expert Opinion on Pharmacotherapy, Vol.3, Iss.10, 2002-10, pp. : 1443-1450
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
"Reasonable cost" for chlamydia screening in young adults
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 496, 2006-01 ,pp. :
Access to resources
Recommend
By Hiligsmann Mickaël Gathon Henry-Jean Bruyère Olivier Ethgen Olivier Rabenda Véronique Reginster Jean-Yves
Value in Health, Vol. 13, Iss. 4, 2010-06 ,pp. :
By Purshouse Robin C. Brennan Alan Rafia Rachid Latimer Nicholas R. Archer Rachel J. Angus Colin R. Preston Louise R. Meier Petra S.
Alcohol and Alcoholism, Vol. 48, Iss. 2, 2013-03 ,pp. :
Cost–effectiveness analysis in pharmacogenomics
By Payne Katherine Shabaruddin Fatiha H
Pharmacogenomics, Vol. 11, Iss. 5, 2010-05 ,pp. :
NAAT-based chlamydia screening cost effective in women and men
Inpharma, Vol. 1, Iss. 1624, 2008-01 ,pp. :